Orion Industries logo

Speciality Medicines IPO Financials

20 March - 24 March 2026 Closed
Sme BSE

The Speciality Medicines IPO is a book build issue with a total issue size of ₹29 cr, comprising of fresh issue of 2200000 equity shares. Speciality Medicines IPO opened for subscription on Mar 20, 2026 and closed on Mar 24, 2026. Speciality Medicines IPO is set price band at ₹117 to ₹124 per share, with a lot size of 1000 shares. Minimum investment for Retail investors was ₹248,000.00 (at the upper price band) to apply for one lot.

The basis of allotment got finalized on Mar 25, 2026, and listed on both the NSE and BSE on Mar 30, 2026.

Skyline Financial Services Private Ltd has been appointed as the registrar. Unistone Capital Pvt Ltd are the Book Running Lead Manager for the issue.

Before investing in the Speciality Medicines IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.

*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.

Speciality Medicines Limited Financials (₹ in Crores)

Particular 31 Oct 2025 31 Mar 2025 31 Mar 2024
Assets 45.57 39.98 22.68
Revenue 36.93 58.54 27.66
Profit After Tax 6.06 8.61 2.93
Net Worth 36.47 30.42 15.06
Reserve & Surplus 30.04 23.98 9.95
Total Borrowings 4.81 5.05 2.86

EPS Pre

13.38%

EPS Post

11.82%

P/E Pre

9.27

P/E (Post Issue)

10.49x

Company Financial Information

Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.

Frequently Asked Questions

Everything you need to know before applying to an IPO.

Speciality Medicines IPO is a Book-building IPO with a total issue size of ₹29 crore. The Speciality Medicines IPO price band is ₹117 to 124 per share. The Speciality Medicines IPO subscription opens on Fri, Mar 20, 2026, and closes on Tue, Mar 24, 2026. The Speciality Medicines IPO will be listed on the BSE. Skyline Financial Services Private Ltd is the registrar for the Speciality Medicines IPO.

The Speciality Medicines IPO opens on Fri, Mar 20, 2026 and closes on Tue, Mar 24, 2026

Speciality Medicines IPO Price Band is ₹117 to 124 per share.

Speciality Medicines IPO lot size is 1000 shares, Retail investors need a minimum investment of ₹248000 based on the upper price band

The minimum investment for Speciality Medicines IPO is ₹248000, based on one lot of 1000 shares at the upper price band of ₹124 per share.

Investors can apply for the Speciality Medicines IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Tue, Mar 24, 2026. The application amount remains blocked until the Speciality Medicines IPO allotment is finalized.

Speciality Medicines IPO issue size is ₹29 crores.

Speciality Medicines IPO allotment date is Wed, Jul 1, 2026.

The registrar for Speciality Medicines IPO is Skyline Financial Services Private Ltd. Investors can go to Skyline Financial Services Private Ltd website to check Speciality Medicines IPO allotment status, refund processing, and other IPO-related information.